PhysioFlow and Covid19

Noninvasive hemodynamics help in managing Covid19 survivors

PhysioFlow is a world-wide reference for noninvasive analysis of hemodynamic abnormalities (cardiac output and heart function), at rest and during exercise. It benefits from clinical recommendations from the AHA and ESC for cardiopulmonary exercise testing in heart failure, among others. Covid19 survivors may be mainly suffering from lung damages, but it is critical to evaluate their cardiac function and reserve during exercise. The goal is to optimize their rehabilitation and recovery and make them safer.